Tissue Substitution refers to the replacement of damaged or lost biological tissues with synthetic or bioengineered alternatives. This approach is employed when the body's natural regenerative capacity is insufficient for complete tissue repair. Tissue substitution strategies include the use of implants, grafts, or tissue-engineered constructs designed to mimic the structure and function of the native tissue. Examples include joint prostheses in orthopedics, artificial heart valves in cardiovascular surgery, and synthetic skin grafts for treating severe burns. Advances in biomaterials and tissue engineering have expanded the possibilities for tissue substitution, aiming to provide more effective and long-lasting solutions. Biocompatible materials, such as polymers or ceramics, are often used to create implants that integrate seamlessly with the surrounding tissues. Tissue engineering techniques involve the fabrication of complex, living constructs that promote host tissue integration and regeneration. The success of tissue substitution relies on the compatibility of materials, proper surgical techniques, and the ability of the substitute to withstand mechanical forces and biological interactions within the body. Ongoing research in tissue substitution focuses on improving biomaterial properties, enhancing biointegration, and expanding the range of tissues that can be effectively substituted, contributing to advancements in regenerative medicine and personalized healthcare.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy